Lv3
390 积分 2024-12-24 加入
Phosphodiesterase 4B (PDE4B) inhibitors and their applications in recent years (2014 to early 2025)
2天前
已完结
PDE4B Inhibition: Exploring the Landscape of Chemistry Behind Specific PDE4B Inhibitors, Drug Design, and Discovery
3个月前
已完结
Role of 'dual Antifibrotic combination' Nintedanib plus Pirfenidone in Idiopathic Pulmonary Fibrosis: A favourable outcome & recommendation to change from monotherapy to combination regimen in a single center experience of 105 IPF cases
4个月前
已关闭
Fixed-dose dry powder for inhalation of nintedanib, pirfenidone and mycophenolic acid by thin-film freezing (TFF) technology
4个月前
已完结
Exercise Pathophysiology in Interstitial Lung Disease
5个月前
已完结
Pulmonary Hypertension in Interstitial Lung Disease
5个月前
已完结
Pathogenesis of chronic bronchitis
6个月前
已关闭
Chronic bronchitis – new clinical recommendations (main provisions): A review on behalf of the working group for the development and revision of clinical guidelines for chronic bronchitis
6个月前
已完结
Advances in the development of antimicrobial peptides and proteins for inhaled therapy
6个月前
已完结
[Research prospect of cyclic nucleotide phosphodiesterase 3/4 inhibitors in chronic obstructive pulmonary disease]
10个月前
已完结
皖公网安备34019202002308
